Rifapentine
- Generic Name
- Rifapentine
- Brand Names
- Priftin
- Drug Type
- Small Molecule
- Chemical Formula
- C47H64N4O12
- CAS Number
- 61379-65-5
- Unique Ingredient Identifier
- XJM390A33U
Overview
Rifapentine is an antibiotic drug used in the treatment of tuberculosis. It inhibits DNA-dependent RNA polymerase activity in susceptible cells. Specifically, it interacts with bacterial RNA polymerase but does not inhibit the mammalian enzyme.
Background
Rifapentine is an antibiotic drug used in the treatment of tuberculosis. It inhibits DNA-dependent RNA polymerase activity in susceptible cells. Specifically, it interacts with bacterial RNA polymerase but does not inhibit the mammalian enzyme.
Indication
For the treatment of pulmonary tuberculosis.
Associated Conditions
- Active Tuberculosis
- Late phase Tuberculosis
Clinical Trials
FDA Approved Products
Priftin
Manufacturer:RPK Pharmaceuticals, Inc.
Route:ORAL
Strength:150 mg in 1 1
Approved: 2018/07/06
NDC:53002-1718
Priftin
Manufacturer:sanofi-aventis U.S. LLC
Route:ORAL
Strength:150 mg in 1 1
Approved: 2018/07/06
NDC:0088-2102
Priftin
Manufacturer:A-S Medication Solutions
Route:ORAL
Strength:150 mg in 1 1
Approved: 2018/07/06
NDC:50090-5063
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath